Molecular Approach to Diagnosis of Cardiovascular Implantable Electronic Device Infection.
Sonicate fluid (SF), a solution derived from vortexing and sonication of explanted cardiovascular implantable electronic devices (CIED), is a higher-yield specimen compared to swabs or tissues for culture-based detection of microorganisms associated with CIED infection. Despite this, SF culture fails to identify a causative organism in ~50% of cases. We aimed to evaluate the diagnostic performance of 16S ribosomal RNA gene (rRNA) PCR/sequencing of SF and compare it to that of SF culture. We identified 322 SF specimens from extracted CIEDs and reviewed clinical data for each patient. Subjects were classified as having or not having CIED infection. Cases were sub-categorized as "culture-negative" if no significant growth was reported from SF cultures and as "culture-positive" if an organism was detected above pre-defined thresholds. 16S rRNA PCR/sequencing was performed, with the organisms identified reported according to CLSI guidelines for sequence data interpretation. A total of 278 SF samples corresponded to infected cases, of which 160 were culture-positive and 118 culture-negative. The remaining 44 were from non-infected cases, of which two were culture-positive. As compared to SF culture, the sensitivity of 16S rRNA PCR/sequencing was higher (64% vs 57.5%, P = 0.003). 16S rRNA PCR/sequencing detected a potential pathogen in 28/118 of culture-negative cases, identifying staphylococci in the majority (18/28). 16S rRNA PCR/sequencing has higher sensitivity to detect bacteria in SF from extracted CIEDs than does SF culture.